THE 60-SECOND GUIDE
Calcitonin
Established biology · indication-specific medicine.
Guide prepared November 13, 2026 · profile review dates retained
What is it?
Calcitonin is a hormone involved in calcium regulation and the control of bone resorption. Medicinal calcitonin products have particular uses and limitations; the hormone’s normal biological role does not make every formulation a general treatment for stronger bones. [1]
Potential benefits
Inhibits osteoclast-mediated bone resorption. Drug forms have had indication-specific uses in disorders involving bone or calcium. Helped establish modern calcium-regulation physiology. [1]
Evidence & its limits
The calcitonin-salmon nasal-solution label warns of a possible malignancy association and calls for periodic reassessment of continued therapy. That concern belongs beside the benefits, not hidden in the references. Evidence and indications must be read for the particular formulation. [1]
Risks & unknowns
Drug products can cause nausea, flushing, nasal irritation, hypocalcemia, or hypersensitivity. Formulation-specific labeling and long-term benefit-risk questions matter. It is not a universal bone-building treatment. [1]
Status & scope
Medicinal calcitonin products have formulation-specific uses and limitations. Read the exact label; the nasal formulation carries a possible malignancy concern and requires benefit-risk reassessment. [1]
The question to ask
Does the evidence match the exact product, route, condition and outcome being discussed? Check the full record and its review dates. This summary is selective; the product label and clinical assessment contain additional warnings and contraindications.
CHECK THE RECORD
Sources & review
- Full evidence record, references and review dates
- FDA Drugs@FDA
- Original 1962 paper
- MedlinePlus: medication-specific uses and precautions
Guide prepared November 13, 2026 · profile review dates retained. Condensed from the linked site evidence record. This format update is not a new clinical review of every source. Consult the full profile for its evidence-review dates and targeted updates.
Selective educational summary, not treatment or dosing advice. Existing profile review dates retained; no independent clinical review.